Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.1% ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...
Once considered an urban disease, non-alcoholic fatty liver is now spreading across rural India as well, fuelled by changing diets, alcohol consumption and poor sleep. Firstpost explores expert ...
Curiously coincidental timing of separate policy statements from frozen food and dairy groups could mean FDA and USDA are ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
Welcome to Wrinkles Week on the Strategist, where we’re deeply vetting skin-care solutions for anyone who’s looking to smooth ...
Cheese is usually the definition of comfort, melting on pizza, topping crackers, or eaten straight from the fridge at ...
In the first human test, an enzyme-converted kidney was transplanted into a brain-dead recipient with family consent, ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
A different type of jack-o’-lantern to look for this time of year, one that has remained unchanged for millennia, and, in my ...
In tech, we love our KPIs—user growth, engagement, efficiency. In food tech, the industry celebrates taste and price. But in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback